Zimbabwe Pharmaceuticals & Healthcare Q2 2018
Zimbabwe’s small and extremely underdeveloped pharmaceutical market currently presents very few opportunities formultinational drugmakers, with many essential medicines funded by international donations. Under President Robert Mugabe, thepublic healthcare sector received only minor contributions from the government, partly a result of growing public debt. Followingthe successful replacement of Mugabe with the more reform-minded President Emmerson Mnangagwa in late 2017, we hold amore optimistic outlook. Despite the substantial headwinds facing the Zimbabwean economy, we believe the government will moveforward with reforms, facilitating an acceleration in growth and gradually improving its unattractive business environment.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook